Contributor Page
Norton Rose Fulbright Canada LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 416 2164000
Fax: +1 416 2163930
Suite 3800
Royal Bank Plaza, South Tower
200 Bay Street, P.O. Box 84
Ontario M5J 2Z4
Contributor Most Read
Contributor Most Read
By Alan Harvie
The Office of the Auditor General of Canada has released an audit report by the Canadian Commissioner of the Environment and Sustainable Development on the enforcement by ECCC of regulations to control toxic substances ...
By Linda Fuerst
The Panel denied both requests.
By Daniel Leslie
On September 30, 2018, Canada and the United States announced they had reached a resolution on certain trade issues and agreed on the text of a new trilateral trade agreement with Mexico to be called the United States-Mexico-Canada Agreement.
By Trevor Zeyl
To that end, shareholder activists have developed a variety of M&A-related strategies.
By Lisa Cabel
Welcome to Motion—Discussing what matters, a video series covering hot topics across the country where our experienced lawyers provide timely legal analysis on issues relevant to Canadians.
By Saam Pousht-Mashhad
The legal noose is tightening around the necks of rogue cryptocurrency issuers in Quebec. PlexCorps's legal troubles, as covered in our previous post, have deepened.
By Peter Choi
In Re Davis, 2018 BCSECCOM 284, the British Columbia Securities Commission upheld permanent market prohibitions against Mr. Davis who committed fraud on one investor in the aggregate...
By Troy Ungerman
Investors are struggling to price market uncertainties, with widely fluctuating market prices in both the United States and Canada.
By Nader Hasan
The CSA has issued Staff Notice 51-357 Staff Review of Reporting Issuers in the Cannabis Industry, which identifies deficiencies in the disclosure practices of issuers involved in the rapidly growing cannabis industry.
By Ryan Berger
Like many organizations in Canada, yours is probably not fully prepared for the mandatory breach reporting requirements coming into force under the federal Personal Information Protection and Electronic Documents Act (PIPEDA) November 1, 2018.
By Christopher Guerreiro, Kristin Wall, Judith Robinson
As we reported, Canada has joined a new trilateral trade deal called the United States-Mexico-Canada Agreement (USMCA).
By Jillian Hyslop, Kristin Wall, Sara Zborovski
Health Canada recently published a notice outlining its phase III pre-market transparency initiatives for prescription drugs.
By Rika Sawatsky
Recreational cannabis will become legal in Canada effective October 17, 2018.
By Sara Zborovski
On October 9, U.S. Customs and Border Protection (the CBP) released a Statement on Canada's Legalization of Marijuana and Crossing the Border.
By Amanda Ferriss
The authors argue that confidentiality agreements and fiduciary duties can be used to help mitigate the foregoing risks.
Contributor's Topics